FDA Approves New Drug

A new drug has just been approved by the FDA to treat atrial fibrillation, a heart rhythm disease that affects approximately 2.5 million people nationwide. This new drug, Multaq, helps maintain and restore normal heart rhythm to patients. According to the New York Times, "the drug will give doctors the first new medicine in years to treat people with atrial fibrillation or atrial flutter. The F.D.A had previously rejected Multaq for more severe heart problems, citing an increased risk of death." The box will carry a warning label to stop those patients who suffer from serious heart conditions from using the drug as a remedy. But for the million of people who suffer from atrial fibrillation, new advancements in science and technology is welcomed and may help save lives.